Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ExtendicareEXETF +0.44%71 Earnings per Share (Diluted) is $0.99 as of Mar. 2026. GuruFocus rates EXETF with a GF Score™ of 71/100 and a GF Value™ of $10.15 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 509 Healthcare Providers & Services companies, Extendicare ranks better than 99.41% on this metric.
Extendicare's EPS (Basic) for the
three
months ended in Mar. 2026 was $0.31.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $1.01.
Extendicare's EPS without NRI for the
three
months ended in Mar. 2026 was $0.26.
Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was $0.89.
During the past 12 months, Extendicare's average EPS without NRIGrowth Rate was 36.70% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 173.60% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 34.20% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 8.10% per year.
During the past 13 years, Extendicare's highest 3-Year average EPS without NRI Growth Rate was 261.80% per year. The lowest was -74.30% per year. And the median was -6.40% per year.
Extendicare (OTCPK:EXETF) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Extendicare Earnings per Share (Diluted) Related Terms
Extendicare Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Extendicare's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EXETF vs HCA, THC, DVA: Earnings per Share (Diluted) Comparison
For the Medical Care Facilities subindustry, Extendicare's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Extendicare PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Extendicare's PE Ratio distribution charts can be found below:
* The bar in red indicates where Extendicare's PE Ratio falls into.
Extendicare Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Extendicare's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.99
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of $0.99 mean?
Extendicare (EXETF) has a Earnings per Share (Diluted) of $0.99 as of Mar. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Extendicare and its competitors. According to the industry distribution chart, Extendicare ranks #3 out of 509 companies in the Healthcare Providers & Services industry, placing it in the top 0.59999999999999%.
Is Extendicare's Earnings per Share (Diluted) too high?
Extendicare's current Earnings per Share (Diluted) is $0.99. The Healthcare Providers & Services industry median Earnings per Share (Diluted) is 11.50. Extendicare's value of $0.99 is 91.4% below this industry median. Based on the distribution chart, Extendicare ranks #3 out of 509 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Extendicare has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Extendicare's Earnings per Share (Diluted) compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Extendicare ranks #3 out of 509 companies for Earnings per Share (Diluted). This places Extendicare in the top 1% of its industry — outperforming the majority of peers. The industry median Earnings per Share (Diluted) is 11.50. Extendicare's value of $0.99 is 91.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Healthcare Providers & Services company?
The median Earnings per Share (Diluted) among Healthcare Providers & Services companies is 11.50, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Extendicare's current Earnings per Share (Diluted) of $0.99 is 91.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Extendicare and its competitors. For the Healthcare Providers & Services industry, the median Earnings per Share (Diluted) is 11.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Extendicare's current Earnings per Share (Diluted) is $0.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Extendicare stock overvalued right now?
Based on GuruFocus' analysis, Extendicare (EXETF) is currently considered Significantly Overvalued. The stock's GF Value™ is $10.15, compared to a current price of $27.31 — trading 169.1% above its estimated fair value. The current Earnings per Share (Diluted) is $0.99 and 91.4% below the Healthcare Providers & Services industry median of 11.50. Extendicare's overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Extendicare (EXETF), the current Earnings per Share (Diluted) is $0.99 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Extendicare (EXETF) Overvalued in 2026?
Based on GuruFocus' analysis, Extendicare stock appears to be overvalued.
The current stock price of $27.31 is trading 169.1% above its estimated GF Value™ of $10.15.
GuruFocus considers Extendicare to be Significantly Overvalued.
Key valuation signals for EXETF:
Earnings per Share (Diluted): $0.99
GF Value™: $10.15 vs. price of $27.31 (169.1% above fair value)
Industry Position: 91.4% below the Healthcare Providers & Services median (#3 of 509)
No single metric tells the full story. See the EXETF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Extendicare Inc is a senior care provider in Canada, focused on long-term care and home health care. The has three main business segments: Long-term Care (LTC), Home Health Care, and Managed Services. The Long-term Care segment, operating under the Extendicare brand, represents 53 owned homes in Ontario, Alberta and Manitoba. The Home Health Care segment, operating under the ParaMed brand, provides home health care services annually in Ontario, Alberta, Manitoba and Nova Scotia. The Managed Services segment, operating under the Extendicare Assist and SGP Purchasing Partner Network brands, provides management, consulting and group purchasing services to other care providers across Canada. The majority of the company's revenue is derived from the Long-term Care segment.
71GF Score
Get the complete analysis for EXETF
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EXETF has been successfully added to your 
